Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · IEX Real-Time Price · USD
26.08
-0.48 (-1.83%)
Jul 22, 2024, 10:13 AM EDT - Market open
Dianthus Therapeutics Employees
Dianthus Therapeutics had 53 employees as of December 31, 2023. The number of employees increased by 21 or 65.63% compared to the previous year.
Employees
53
Change (1Y)
21
Growth (1Y)
65.63%
Revenue / Employee
$42,547
Profits / Employee
-$799,208
Market Cap
766.02M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 53 | 21 | 65.63% |
| Dec 31, 2022 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Embecta | 2,200 |
| Phibro Animal Health | 1,920 |
| Aurinia Pharmaceuticals | 300 |
| Evolus | 273 |
| OrthoPediatrics | 247 |
| Simulations Plus | 197 |
| Olema Pharmaceuticals | 74 |
| Abivax | 61 |
DNTH News
- 23 days ago - Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN) - GlobeNewsWire
- 5 weeks ago - Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN) - GlobeNewsWire
- 7 weeks ago - Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results - GlobeNewsWire
- 2 months ago - Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference - GlobeNewsWire
- 2 months ago - Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual Meeting - GlobeNewsWire
- 4 months ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results - GlobeNewsWire